Regeneron STS finalists meet pioneering scientists at Janelia Research Campus
For Regeneron Science Talent Search finalists, Finals Week in Washington, D.C. is jampacked with activities. Beyond the competition and their interviews
Stay updated with breaking news from Ronald Vale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For Regeneron Science Talent Search finalists, Finals Week in Washington, D.C. is jampacked with activities. Beyond the competition and their interviews
For Regeneron Science Talent Search finalists, Finals Week in Washington, D.C. is jampacked with activities. Beyond the competition and their interviews
Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials Myeloid's cell therapy harnesses the innate capabilities of myeloid lineage cells to fight cancer Scientific founders include world-renowned cell therapy & cancer experts Ronald Vale, Ph.D. and Siddhartha Mukherjee, M.D., D.Phil. Co-Founded by Thomas Cahill, M.D., Ph.D., with financing led by Newpath Partners and participation from leading biotech investors News provided by Share this article Share this article CAMBRIDGE, Mass., Jan. 6, 2021 /PRNewswire/ -- Myeloid Therapeutics, Inc., a company harnessing...